Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Overland Park, Kansas
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Overland Park, Kansas
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Shawnee Mission, Kansas
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Conditions: Brain and Central Nervous System Tumors
Location: Lawrence, Kansas
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuke
Conditions: Leukemia
Location: Lawrence, Kansas
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Topeka, Kansas
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Lawrence, Kansas
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Topeka, Kansas
- Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
Conditions: Lymphoma
Location: Overland Park, Kansas
- Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
Conditions: Lymphoma
Location: Overland Park, Kansas
- Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
Conditions: Lymphoma
Location: Shawnee Mission, Kansas
- Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Lawrence, Kansas
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Overland Park, Kansas
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Overland Park, Kansas
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Shawnee Mission, Kansas
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Topeka, Kansas
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Topeka, Kansas
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Lawrence, Kansas
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Overland Park, Kansas
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Overland Park, Kansas
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Shawnee Mission, Kansas
- Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Lawrence, Kansas
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer
Location: Lawrence, Kansas
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer
Location: Overland Park, Kansas
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer
Location: Shawnee Mission, Kansas
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
Location: Lawrence, Kansas
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Lawrence, Kansas
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Topeka, Kansas
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Lawrence, Kansas
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III
Conditions: Lung Cancer
Location: Overland Park, Kansas
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III
Conditions: Lung Cancer
Location: Overland Park, Kansas
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III
Conditions: Lung Cancer
Location: Shawnee Mission, Kansas
- Examining Heart Attacks in Young Women
Conditions: Myocardial Infarction
Location: Topeka, Kansas
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Topeka, Kansas
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Overland Park, Kansas
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Overland Park, Kansas
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Shawnee Mission, Kansas
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Lawrence, Kansas
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Lawrence, Kansas
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Overland Park, Kansas
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Overland Park, Kansas
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Shawnee Mission, Kansas
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Topeka, Kansas
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Topeka, Kansas
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Topeka, Kansas
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Lawrence, Kansas
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Overland Park, Kansas
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Overland Park, Kansas
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Shawnee Mission, Kansas
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Topeka, Kansas
- A Complicated Skin and Soft-Tissue Infection Patient Registry
Conditions: Abscess - Staphylococcal Skin Infections - Diabetic Foot Infections - Surgical Wound Infection - Cellulitis
Location: Topeka, Kansas
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Lawrence, Kansas
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Lawrence, Kansas
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Overland Park, Kansas
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Overland Park, Kansas
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Shawnee Mission, Kansas
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Topeka, Kansas
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Lawrence, Kansas
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Topeka, Kansas
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Lawrence, Kansas
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Overland Park, Kansas
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Overland Park, Kansas
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Shawnee Mission, Kansas
- Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
Conditions: Impetigo - Secondarily-infected Traumatic Lesions - Skin Diseases, Bacterial
Location: Overland Park, Kansas
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Lawrence, Kansas
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Lawrence, Kansas
- Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Lawrence, Kansas
- Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Conditions: Asthma
Location: Topeka, Kansas
- Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Conditions: Diabetic Macular Edema
Location: Prairie Village, Kansas
- Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Au
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Lawrence, Kansas
- Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
Conditions: Palmar-Plantar Erythrodysesthesia - Breast Cancer
Location: Overland Park, Kansas
- Comparison of 1 vs 3 Sets of Resistance Training on Muscular Hypertrophy
Conditions: Resistance Training - Obesity
Location: Lawrence, Kansas
- Whey Protein, Resistance Training, and Changes in Body Composition
Conditions: Obesity
Location: Lawrence, Kansas
- Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain
Conditions: Neuropathic Pain
Location: Leawood, Kansas
- FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study
Conditions: Kidney Failure, Chronic - End Stage Renal Disease, Requiring Dialysis
Location: Topeka, Kansas
- Randomized On-X Anticoagulation Trial
Conditions: Heart Valve Disease
Location: Topeka, Kansas
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Topeka, Kansas
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Overland Park, Kansas
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Topeka, Kansas
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Lawrence, Kansas
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Overland Park, Kansas
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Overland Park, Kansas
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Prairie Village, Kansas
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Topeka, Kansas
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Topeka, Kansas
- PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Conditions: Benign Prostatic Hyperplasia (BPH)
Location: Overland Park, Kansas
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Topeka, Kansas
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Overland Park, Kansas
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Overland Park, Kansas
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Overland Park, Kansas
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Topeka, Kansas
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Overland Park, Kansas
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Overland Park, Kansas
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Prairie Village, Kansas
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Lawrence, Kansas
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Overland Park, Kansas
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Overland Park, Kansas
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Prairie Village, Kansas
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Lawrence, Kansas
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Topeka, Kansas
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Topeka, Kansas
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Lawrence, Kansas
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Overland Park, Kansas
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Overland Park, Kansas
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Prairie Village, Kansas
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Lawrence, Kansas
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Overland Park, Kansas
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Overland Park, Kansas
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Prairie Village, Kansas
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Topeka, Kansas
- Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Conditions: Myelogenous Leukemia, Chronic
Location: Overland Park, Kansas
- Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy
Conditions: Metastatic Breast Cancer
Location: Topeka, Kansas
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Lawrence, Kansas
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Overland Park, Kansas
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Overland Park, Kansas
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Prairie Village, Kansas
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Topeka, Kansas
- Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Conditions: Healthy
Location: Leawood, Kansas
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Overland Park, Kansas
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Topeka, Kansas
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Lawrence, Kansas
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Lawrence, Kansas
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Overland Park, Kansas
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Overland Park, Kansas
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Prairie Village, Kansas
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Lawrence, Kansas
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Overland Park, Kansas
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Overland Park, Kansas
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Prairie Village, Kansas
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Topeka, Kansas
- Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
Conditions: Leukemia
Location: Lawrence, Kansas
- Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
Location: Lawrence, Kansas
- Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
Location: Overland Park, Kansas
- Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lympho
Conditions: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
Location: Overland Park, Kansas
- A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
Location: Topeka, Kansas
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Lawrence, Kansas
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Lawrence, Kansas
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Overland Park, Kansas
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Prairie Village, Kansas
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Overland Park, Kansas
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Overland Park, Kansas
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Prairie Village, Kansas
- Longitudinal Surveillance Registry (LSR) of ACUITY Spiral
Conditions: Heart Failure
Location: Overland Park, Kansas
- Vorinostat, Rituximab, and Combination Chemotherapy In Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Lymphoma
Location: Lawrence, Kansas
- Home-Based Programs for Improving Sleep in Cancer Survivors
Conditions: Cancer Survivor - Fatigue - Psychosocial Effects of Cancer and Its Treatment - Sleep Disorders
Location: Lawrence, Kansas
- Intravitreal Ranibizumab for VH Due to PDR (N)
Conditions: Vitreous Hemorrhage - Proliferative Diabetic Retinopathy
Location: Leawood, Kansas
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Lawrence, Kansas
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Overland Park, Kansas
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Overland Park, Kansas
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Prairie Village, Kansas
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Overland Park, Kansas
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Overland Park, Kansas
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Prairie Village, Kansas
- Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Lawrence, Kansas
- Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Conditions: Prostate Cancer
Location: Topeka, Kansas
- Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
Conditions: Hereditary Angioedema
Location: Overland Park, Kansas
- Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for
Conditions: Fungal Infection
Location: Kansas City, Kansas
- Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After
Conditions: Colorectal Cancer
Location: Lawrence, Kansas
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Rec
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Lawrence, Kansas
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage II
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Lawrence, Kansas
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Overland Park, Kansas
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Overland Park, Kansas
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Prairie Village, Kansas
- A Cooperative Clinical Study of Abatacept in Multiple Sclerosis
Conditions: Multiple Sclerosis, Relapsing-Remitting
Location: Lenexa, Kansas
- Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Lawrence, Kansas
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Lawrence, Kansas
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Topeka, Kansas
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Lawrence, Kansas
- Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
Conditions: Endometrial Cancer
Location: Lawrence, Kansas
- Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Canc
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
Location: Lawrence, Kansas
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Lawrence, Kansas
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Overland Park, Kansas
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Overland Park, Kansas
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Prairie Village, Kansas
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Topeka, Kansas
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Topeka, Kansas
- Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Conditions: Head and Neck Cancer - Mucositis - Oral Complications of Radiation Therapy - Pain
Location: Lawrence, Kansas
- Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Conditions: Orthostatic Hypotension - Parkinson's Disease
Location: Topeka, Kansas
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use NSAIDs and/or Colchicine.
Conditions: Acute Gout
Location: Overland Park, Kansas
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Conditions: Diarrhea - Gastrointestinal Complications - Unspecified Adult Solid Tumor, Protocol Specific
Location: Lawrence, Kansas
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Overland Park, Kansas
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Overland Park, Kansas
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Prairie Village, Kansas
- Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder
Conditions: Major Depressive Disorder
Location: Overland Park, Kansas
- Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
Location: Overland Park, Kansas
- Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections
Conditions: Moderate Clostridium Difficile Infection
Location: Topeka, Kansas
- Dysport® Adult Lower Limb Spasticity Study
Conditions: Leg Spasticity
Location: Leawood, Kansas
- Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail
Conditions: Onychomycosis of Toenails
Location: Overland Park, Kansas
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Lawrence, Kansas
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Topeka, Kansas
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Topeka, Kansas
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Breast Cancer
Location: Lawrence, Kansas
- Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Conditions: Cognitive/Functional Effects - Colorectal Cancer - Neurotoxicity
Location: Lawrence, Kansas
- Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders
Location: Lawrence, Kansas
- Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Conditions: Cervical Dystonia - Blepharospasm
Location: Leawood, Kansas
- Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Conditions: Cervical Dystonia - Blepharospasm
Location: Overland Park, Kansas
- A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spon
Conditions: Chronic Idiopathic Urticaria
Location: Overland Park, Kansas
- Preventing Child Maltreatment Through A Cellular-Phone Technology-Based Parenting Program
Conditions: Child Maltreatment
Location: Lawrence, Kansas
- To Evaluate the Use of ASTHMA IQ in a Primary Care Setting
Conditions: Asthma
Location: Leawood, Kansas
- Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
Location: Overland Park, Kansas
- A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did
Conditions: Overactive Bladder - Bladder, Overactive - Overactive Urinary Bladder
Location: Overland Park, Kansas
- A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Conditions: Overactive Bladder
Location: Shawnee, Kansas
- Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
Conditions: Type I Diabetes
Location: Topeka, Kansas
- Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
Conditions: Prostate Cancer
Location: Lawrence, Kansas
- Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Conditions: Depression
Location: Prairie Village, Kansas
- A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squ
Conditions: Lung Cancer, Small Cell
Location: Overland Park, Kansas
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Overland Park, Kansas
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Topeka, Kansas
- A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD
Conditions: Pulmonary Disease, Chronic Obstructive
Location: Topeka, Kansas
- Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency
Conditions: Multiple Myeloma - Renal Insufficiency
Location: Topeka, Kansas
- Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
Conditions: Acute Gouty Arthritis
Location: Overland Park, Kansas
- Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
Conditions: Acute Gouty Arthritis
Location: Topeka, Kansas
- Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe
Conditions: Low Back Pain
Location: Leawood, Kansas
- Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe
Conditions: Low Back Pain
Location: Prairie Village, Kansas
- Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Conditions: Depression
Location: Prairie Village, Kansas
- National Marrow Donor Program Long-Term Donor Follow-Up
Conditions: Hematologic Neoplasms
Location: Leawood, Kansas
- Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged
Conditions: Staphylococcal Infections - Staphylococcal Vaccines - Bacterial Infections - Staphylococcal Skin Infections
Location: Overland Park, Kansas
- A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children an
Conditions: Major Depressive Disorder
Location: Overland Park, Kansas
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Conditions: Major Depressive Disorder
Location: Overland Park, Kansas
- Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Conditions: Cancer
Location: Lawrence, Kansas
- Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Conditions: Depression, Bipolar
Location: Prairie Village, Kansas
- Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain
Conditions: Chronic Nonmalignant and Nonneuropathic Pain
Location: Leawood, Kansas
- A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus
Conditions: Healthy
Location: Overland Park, Kansas
- Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regim
Conditions: Moderate to Severe Plaque-type Psoriasis
Location: Overland Park, Kansas
- Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Conditions: Prostate Cancer
Location: Overland Park, Kansas
- Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients
Conditions: Hyperuricemia - Gout
Location: Overland Park, Kansas
- Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotini
Conditions: Colorectal Cancer - Dermatologic Complications - Lung Cancer - Therapy-related Toxicity
Location: Lawrence, Kansas
- Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Conditions: Tourette's Disorder
Location: Overland Park, Kansas
- Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
Conditions: Acute Gouty Arthritis
Location: Overland Park, Kansas
- Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
Conditions: Acute Gouty Arthritis
Location: Topeka, Kansas
- Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
Conditions: Schizophrenia
Location: Topeka, Kansas
- Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)
Conditions: Major Depressive Disorder
Location: Overland Park, Kansas
- A Study in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Topeka, Kansas
- SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Conditions: Major Depressive Disorder
Location: Prairie Village, Kansas
- Safety Study in Patients With Multiple Sclerosis Treated Fingoliomod or Other Approved Disease-modifying Therapies
Conditions: Multiple Sclerosis
Location: Lenexa, Kansas
- Safety Study in Patients With Multiple Sclerosis Treated Fingoliomod or Other Approved Disease-modifying Therapies
Conditions: Multiple Sclerosis
Location: Topeka, Kansas
- Safety Study in Patients With Multiple Sclerosis Treated Fingoliomod or Other Approved Disease-modifying Therapies
Conditions: Multiple Sclerosis
Location: Topeka, Kansas
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Olathe, Kansas
- Apnex Clinical Study of the Hypoglossal Nerve Stimulation (HGNS®) System to Treat Obstructive Sleep Apnea
Conditions: Obstructive Sleep Apnea
Location: Lenexa, Kansas
- Apnex Clinical Study of the Hypoglossal Nerve Stimulation (HGNS®) System to Treat Obstructive Sleep Apnea
Conditions: Obstructive Sleep Apnea
Location: Topeka, Kansas
- Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain
Conditions: Osteoarthritis - Low Back Pain
Location: Leawood, Kansas
- Dose-Escalation Study With ETI-204Placebo-Controlled, Sequential Group, Single Dose, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics
Conditions: Healthy Volunteers
Location: Overland Park, Kansas
- Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Diso
Conditions: Smoking Cessation
Location: Overland Park, Kansas
- Normative Data of Brain Network Activation in Adolescents and Young Adults
Conditions: Healthy Controls
Location: Overland Park, Kansas
- Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke
Conditions: Post-stroke Spasticity of the Lower Limb.
Location: Overland Park, Kansas
- A Study to Evaluate the Efficacy and Safety of ALKS 9072 in Subjects With Schizophrenia
Conditions: Schizophrenia
Location: Overland Park, Kansas
- Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Conditions: Major Depressive Disorder
Location: Prairie Village, Kansas
- A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Conditions: Asthma
Location: Lenexa, Kansas
- A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Conditions: Asthma
Location: Topeka, Kansas
- A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Conditions: Asthma
Location: Topeka, Kansas
|